Condition
Dravet Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Dravet Syndrome clinical trials that are recruiting, at sites in 13 countries (most in United States (5), France (3), Australia (2)). By phase: Phase 1/2 (2), Phase 2 (1), Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 13Countries
Newest Dravet Syndrome clinical trials
All recruiting trials (9)
-
ION337 safety and tolerability in children with Dravet syndrome
This will test whether ION337 is safe and well tolerated in children ages 2 to 12 with Dravet syndrome.
-
Tracking development, seizures, and biomarkers over four years in children and young adults with SCN1A-related Dravet syndrome
This project will follow children and young people with SCN1A-related Dravet syndrome for four years to see how their development, seizure patterns, and blood metabolite markers change over time.
-
Fintepla for Dravet Syndrome: testing brain blood flow and connections
This study tests how Fintepla affects brain blood flow and network connections in Dravet syndrome patients who have convulsive seizures.
-
PET‑MRI mapping of brainstem serotonin pathways in adults with Dravet syndrome
This uses a PET‑MRI scan with the tracer [18F]MPPF to see if serotonin pathways in the brainstem differ in adults with Dravet syndrome compared with healthy controls.
-
Testing BMB-101 for Absence Epilepsy and Related Conditions
This study is testing a new treatment called BMB-101 to see if it can help reduce seizures in people with Absence Epilepsy and related conditions.
-
Measuring GABA Levels in Children with Dravet Syndrome
This study is trying to measure GABA levels in the brains of children with Dravet Syndrome to see how they compare to kids without the condition, hoping to find new ways to understand and treat the syndrome.
-
Evaluating ETX101 for treating Dravet syndrome in young children
This study is testing a new treatment called ETX101 to see if it can help reduce seizures in young children with Dravet syndrome.
-
Real-life follow-up of rare epilepsies in children and adolescents
This project will follow children and teens with rare epilepsies to see how they respond to treatments and how cognitive and psychiatric problems change over time.
-
Evaluating clemizole hydrochloride for treating Dravet syndrome
This study is testing if clemizole hydrochloride can help children and adults with Dravet syndrome who still have seizures despite taking other medications.
Related topics
Quick answers
How many Dravet Syndrome clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (5 trials), France (3 trials), Australia (2 trials), Canada (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.